THE EFFECTS OF (+/-)-IDAZOXAN AND ITS STEREOISOMERS ON MOUSE VAS-DEFERENS MOTILITY INVITRO - A COMPARISON WITH YOHIMBINE

被引:2
作者
CARRATU, MR
NAVARRA, P
DESERIO, A
SERIO, M
PREZIOSI, P
MITOLOCHIEPPA, D
机构
[1] UNIV CATTOLICA SACRO CUORE, SCH MED, INST PHARMACOL, LARGO F VITO 1, I-00168 ROME, ITALY
[2] UNIV BARI, SCH MED, INST PHARMACOL, I-70124 BARI, ITALY
关键词
IDAZOXAN STEREOISOMER; PARA-AMINOCLONIDINE; YOHIMBINE; NOREPINEPHRINE; VASDEFERENS; IMIDAZOLINE RECEPTOR;
D O I
10.1111/j.1472-8206.1992.tb00124.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of idazoxan (IDZ) and its stereoisomers were compared to that of a classical alpha2-antagonist, yohimbine (YOH), on para-aminoclonidine (PAC)- and norepinephrine (NE)-mediated inhibition of the twitch response evoked in the mouse vas deferens by low-frequency (0.1 Hz) field stimulation. (+/-)-IDZ and (+)-IDZ antagonized the inhibitory effects of PAC, (+)-IDZ being twice as potent as (+/-)-IDZ; in contrast, antagonism by (-)-IDZ failed to meet Schild criteria for a competitive mechanism. YOH completely reversed the inhibition of twitch response induced by NE, but not that induced by PAC; in the latter case, residual inhibition was almost fully reversed by (+)-IDZ and to a lesser extent by (+/-)-IDZ, while (-)-IDZ proved ineffective. These results provide pharmacological evidence of alpha2-receptor heterogeneity at the vas deferens level. A possible additional mechanism involving imidazoline binding sites is discussed.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 25 条
[1]   EVIDENCE AGAINST ADRENERGIC MOTOR TRANSMISSION IN GUINEA PIG VAS DEFERENS [J].
AMBACHE, N ;
ZAR, MA .
JOURNAL OF PHYSIOLOGY-LONDON, 1971, 216 (02) :359-&
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   CLONIDINE-DISPLACING SUBSTANCE (CDS) AND ITS PUTATIVE IMIDAZOLINE RECEPTOR - NEW LEADS FOR FURTHER DIVERGENCE OF ALPHA-2-ADRENERGIC RECEPTOR ACTIVITY [J].
ATLAS, D .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) :1541-1549
[4]  
BOUSQUET P, 1985, TRENDS AUTONOMIC PHA, P213
[5]  
BOYAJIAN CL, 1987, J PHARMACOL EXP THER, V241, P1092
[6]   THE IMIDAZOLINE PREFERRING RECEPTOR - BINDING-STUDIES IN BOVINE, RAT AND HUMAN BRAIN-STEM [J].
BRICCA, G ;
DONTENWILL, M ;
MOLINES, A ;
FELDMAN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :1-9
[7]   ALPHA-2-ADRENOCEPTOR SUBTYPES AND IMIDAZOLINE-LIKE BINDING-SITES IN THE RAT-BRAIN [J].
BROWN, CM ;
MACKINNON, AC ;
MCGRATH, JC ;
SPEDDING, M ;
KILPATRICK, AT .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (04) :803-809
[8]   HETEROGENEITY OF ALPHA-2 ADRENERGIC-RECEPTORS [J].
BYLUND, DB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 22 (05) :835-843
[9]   COMPARATIVE-EVALUATION OF LISURIDE AND TERGURIDE, ERGOT ALKALOID DERIVATIVES, ON THE FIELD-STIMULATED VAS-DEFERENS OF MOUSE [J].
CARRATU, MR ;
DESERIO, A ;
MITOLOCHIEPPA, D ;
FEDERICO, F .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1991, 84 (03) :221-232
[10]   (IMIDAZOLINYL-2)-2-BENZODIOXANE 1-4 (IDAZOXAN) AND ITS STEREOISOMERS, NEW ALPHA-2-ANTAGONISTS [J].
DABIRE, H ;
MOUILLE, P ;
SCHMITT, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S127-S129